IP Library Granted Patent US 11,834,435
Granted Patent B2
US 11,834,435 · App. 17/944,429 · Granted Dec 5, 2023

SSTR4 agonist salts

Inventors: David Andrew Coates (New Palestine, IN); David Michael Remick (Fishers, IN)
Assignee: Eli Lilly and Company
C07D401/12C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,834,435
App. No.
17/944,429
Granted
Dec 5, 2023
Kind
B2
Abstract

The present invention relates to specific salts of (1S,5R)-(1α,5α,6α)-N-[1,1-dimethyl-2-[(3-methyl-2-pyridyl)oxy]ethyl]-3-azabicyclo[3.1.0]hexane-6-carboxamide, to pharmaceutical compositions comprising said salts, to methods of using said salts to treat physiological disorders, and to intermediates useful in the synthesis of the salts.

Claims (22)

1. A compound of the formula:

wherein the compound is crystalline and is characterized by an X-ray powder diffraction pattern using CuKα radiation comprising peaks at diffraction angle 2-theta 10.6°±0.2° 15.2°±0.2° and 21.9°±0.2°.

2. A compound of the formula:

wherein the compound is crystalline and is characterized by an X-ray powder diffraction pattern using CuKα radiation comprising peaks at diffraction angle 2-theta 5.4°±0.2°, 10.3°±0.2°, 16.2°±0.2°, and 20.8°±0.2°.

3. A compound of formula:

wherein the compound is crystalline and is characterized by an X-ray powder diffraction pattern using CuKα radiation comprising peaks at diffraction angle 2-theta 4.9°±0.2°, 17.3°±0.2°, and 18.1°±0.2°.

4. A pharmaceutical composition comprising the compound of claim 1 and one or more pharmaceutically acceptable carriers, diluents, or excipients.

5. A method of treating pain in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 1 .

6. A method of treating chronic back pain in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 1 .

7. A method of treating neuropathic pain in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 1 .

8. The method of claim 7 , wherein the neuropathic pain is diabetic peripheral neuropathic pain.

9. A method of treating pain associated with osteoarthritis in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 1 .

10. A method of treating pain in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 2 .

11. A method of treating chronic back pain in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 2 .

12. A method of treating neuropathic pain in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 2 .

13. The method of claim 12 , wherein the neuropathic pain is diabetic peripheral neuropathic pain.

14. A method of treating pain associated with osteoarthritis in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 2 .

15. A method of treating pain in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 3 .

16. A method of treating chronic back pain in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 3 .

17. A method of treating neuropathic pain in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 3 .

18. The method of claim 17 , wherein the neuropathic pain is diabetic peripheral neuropathic pain.

19. A method of treating pain associated with osteoarthritis in a patient comprising administering to said patient in need of such treatment an effective amount of the compound of claim 3 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2022
From: COATES, DAVID ANDREW; REMICK, DAVID MICHAEL
To: ELI LILLY AND COMPANY
Reel/Frame 061132/0231 →
Continuity (2)
Provisional Application 63243785 · Sep 14, 2021
Related Publication 20230099116A1 · Mar 30, 2023
Cited By (1)
US 12,486,249